Isometric diagram of a glowing peptide ribbon connected to a composite amylin receptor made of a core receptor and accessory protein in a membrane
Mindful Research

Cagrilintide and the Amylin Pathway in In-Vitro Research

Updated By: Mindful Research Team1 min read

Key takeaways

  • Cagrilintide is studied in vitro as an agonist at amylin-family receptors, distinct from the GLP-1 pathway.
  • Amylin receptors are G-protein-coupled receptors built from a core receptor plus accessory proteins.
  • It is characterized by receptor-binding and cell-based signaling assays (e.g. cyclic AMP).
  • It lets researchers map the amylin pathway alongside the GLP-1 pathway in vitro.
  • Supplied as a research material for in vitro research use only.

Cagrilintide is a research peptide studied in vitro as an agonist at amylin-family receptors, a signaling system distinct from the GLP-1 pathway. This profile describes its target and the assays used to characterize it.

What is cagrilintide?

Cagrilintide is a synthetic peptide used as a reference compound in amylin-receptor research. It is described here only by structure and molecular target, as a laboratory material.

What is the amylin pathway?

Amylin receptors are a group of G-protein-coupled receptors formed from a core receptor paired with accessory proteins. They are a separate signaling system from the GLP-1 receptor, which is why cagrilintide is studied alongside, not in place of, GLP-1 reference compounds.

How is it characterized in the lab?

Characterization uses receptor-binding assays and cell-based signaling readouts (such as cyclic AMP) in cells expressing amylin-family receptors, often compared against other incretin or amylin reference compounds.

Why it matters in receptor research

Having a defined amylin-receptor reference compound lets researchers map the amylin pathway in parallel with the GLP-1 pathway under controlled in-vitro conditions.

Related research guides

Research-use note

Cagrilintide is supplied as a research material for in vitro research use only. It is not for human or animal use.

Related research: Cagrilintide.

Frequently asked questions

What is cagrilintide?

A synthetic peptide used as a reference compound studied in vitro as an agonist at amylin-family receptors.

How is the amylin pathway different from GLP-1?

Amylin receptors are a separate group of G-protein-coupled receptors, so cagrilintide is studied alongside, not in place of, GLP-1 reference compounds.

How is it studied in the lab?

With receptor-binding assays and cell-based signaling readouts such as cyclic AMP in cells expressing amylin-family receptors. View Cagrilintide

Is it research use only?

Yes. It is supplied for in vitro laboratory research use only.

Continue reading

Vial of blue copper-complex lyophilized peptide powder in a cold-storage block, representing KLOW 80 mg handling and stabilityKLOW 80 mg: Copper-Complex Blue Lyophilized Powder, Handling, Stability and Stock Concentration Math The KLOW 80 mg vial is a pale-blue lyophilized powder because one of its four components, GHK-Cu, is a copper(II) complex; reconstituted... Researcher in a lab coat checking a vial of blue peptide blend powder against a four-peak analytical readoutSourcing KLOW as a Research Material: Per-Component COA and Purity Sourcing KLOW as a research material means obtaining, in one Certificate of Analysis, the identity and purity data for all four of... Two vials of blue peptide blend powder side by side, one with an extra tripeptide render, representing GLOW versus KLOWGLOW vs KLOW: What KPV Adds to the Blend (Composition Comparison) The difference between GLOW and KLOW is one component: KLOW adds 10 mg of the tripeptide KPV (Lys-Pro-Val, CAS 67727-97-3) to GLOW's...